DOCUSIGN, INC.·4

Jun 2, 6:53 PM ET

Briggs Teresa 4

4 · DOCUSIGN, INC. · Filed Jun 2, 2026

Research Summary

AI-generated summary of this filing

Updated

DocuSign Director Teresa Briggs Sells 365 Shares, Receives RSU Award

What Happened

  • Teresa Briggs, a director of DocuSign (DOCU), converted/exercised 729 derivative units into common stock on May 29, 2026 (no exercise price), sold 365 shares that same day in an open‑market transaction for about $50.04/share (total $18,265), and on June 1, 2026 was granted 4,384 restricted stock units (RSUs).
  • The sale was effected under a Rule 10b5‑1 plan (footnote F1). The RSU grant carries standard vesting terms (see Key Details).

Key Details

  • Transaction dates & prices:
    • May 29, 2026: Conversion/exercise of 729 derivative units at $0.00 (acquired); open‑market sale of 365 shares at $50.04 each for $18,265 total; a related derivative disposition of 729 units is also reported on May 29.
    • June 1, 2026: Grant of 4,384 RSUs (reported at $0.00 acquisition price).
  • Shares owned after the transactions: Not specified in the provided filing excerpt.
  • Footnotes of note:
    • F1: The May 29 sale was effected pursuant to a Rule 10b5‑1 trading plan.
    • F2–F5: Each RSU converts to one share; the earlier RSUs have a vest commencement date of May 29, 2025 and vest quarterly over one year (with the fourth installment possibly accelerated to the next annual meeting). The June 1, 2026 RSUs vest quarterly over one year starting June 1, 2026; RSUs do not expire.
  • Filing: Form 4 filed June 2, 2026 reporting transactions on May 29 and June 1, 2026.

Context

  • The May 29 activity appears to be conversion/exercise of derivative awards (RSUs or similar) into shares, followed by a partial open‑market sale. Sales under 10b5‑1 plans are typically prearranged and often routine; they do not by themselves indicate the director’s private view of the company. The June 1 RSU grant is a time‑based award that vests in equal quarterly installments over a year (with a potential earlier full vesting of the final installment under the plan terms).

Insider Transaction Report

Form 4
Period: 2026-05-29
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-29+72910,628 total
  • Sale

    Common Stock

    [F1]
    2026-05-29$50.04/sh365$18,26510,263 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3][F4]
    2026-05-297290 total
    Common Stock (729 underlying)
  • Award

    Restricted Stock Units

    [F2][F5][F4]
    2026-06-01+4,3844,384 total
    Common Stock (4,384 underlying)
Footnotes (5)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.
  • [F4]The RSUs do not expire; they either vest or are canceled prior to vesting date.
  • [F5]The RSUs have a vest commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.
Signature
/s/ Derrick Chapman, Attorney-in-fact|2026-06-02

Documents

1 file
  • 4
    wk-form4_1780440815.xmlPrimary

    FORM 4